p21 delays tumor onset by preservation of chromosomal

被引:83
作者
Barboza, Juan A.
Liu, Geng
Ju, Zhenlin
El-Naggar, Adel K.
Lozano, Guillermina
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[3] Univ Texas, Grad Sch Biomed Sci, Houston, TX 77030 USA
关键词
apoptosis; chromosomal instability; p53; tumorigenesis; mouse model;
D O I
10.1073/pnas.0606343104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The p53 protein suppresses tumorigenesis by initiating cellular functions such as cell cycle arrest and apoptosis in response to DNA damage. A p53 mutant, p53R172P, which is deficient for apoptosis but retains a partial cell cycle arrest function, delays tumor onset in mice. Remarkably, lymphomas arising in Trp53(515C/515C) mice (encoding p53R172P) retain stable genomes. Given the dominant role of p21 in p53 cell cycle control, we crossed Tp53(51SC/515C) mice onto a p21-null background to determine whether p21 was required for maintaining chromosomal stability and delaying tumor onset. Loss of p21 completely abolished the cell cycle arrest function of p53R172P and accelerated tumor onset in Trp53(515C/515C) mice. Cytogenetic examination of Trp53(515C/515) cp21(-/-) sarcomas and lymphomas revealed aneuploicly and chromosomal aberrations that were absent in Trp53(515C/515C) malignancies. Thus, p21 coupled p53-dependent checkpoint control and preservation of chromosomal stability, and cooperated with apoptosis in suppressing tumor onset in mice.
引用
收藏
页码:19842 / 19847
页数:6
相关论文
共 43 条
[1]   Histone H2AX: A dosage-dependent suppressor of oncogenic translocations and tumors [J].
Bassing, CH ;
Suh, H ;
Ferguson, DO ;
Chua, KF ;
Manis, J ;
Eckersdorff, M ;
Gleason, M ;
Bronson, R ;
Lee, C ;
Alt, FW .
CELL, 2003, 114 (03) :359-370
[2]   RADIATION-INDUCED CELL-CYCLE ARREST COMPROMISED BY P21 DEFICIENCY [J].
BRUGAROLAS, J ;
CHANDRASEKARAN, C ;
GORDON, JI ;
BEACH, D ;
JACKS, T ;
HANNON, GJ .
NATURE, 1995, 377 (6549) :552-557
[3]   p21 Is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells [J].
Brugarolas, J ;
Bronson, RT ;
Jacks, T .
JOURNAL OF CELL BIOLOGY, 1998, 141 (02) :503-514
[4]   wt p53 dependent expression of a membrane-associated isoform of adenylate kinase [J].
Collavin, L ;
Lazarevic, D ;
Utrera, R ;
Marzinotto, S ;
Monte, M ;
Schneider, C .
ONCOGENE, 1999, 18 (43) :5879-5888
[5]   MICE LACKING P21(C/P1/WAF1) UNDERGO NORMAL DEVELOPMENT, BUT ARE DEFECTIVE IN G1 CHECKPOINT CONTROL [J].
DENG, CX ;
ZHANG, PM ;
HARPER, JW ;
ELLEDGE, SJ ;
LEDER, P .
CELL, 1995, 82 (04) :675-684
[6]   MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS [J].
DONEHOWER, LA ;
HARVEY, M ;
SLAGLE, BL ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A .
NATURE, 1992, 356 (6366) :215-221
[7]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[8]   Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity [J].
Franklin, DS ;
Godfrey, VI ;
O'Brien, DA ;
Deng, CX ;
Xiong, Y .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (16) :6147-6158
[9]  
HARPER JW, 1993, CELL, V75, P805
[10]   Human wig-1, a p53 target gene that encodes a growth inhibitory zinc finger protein [J].
Hellborg, F ;
Qian, W ;
Mendez-Vidal, C ;
Asker, C ;
Kost-Alimova, M ;
Wilhelm, M ;
Imreh, S ;
Wiman, KG .
ONCOGENE, 2001, 20 (39) :5466-5474